drugset / Trial / NCT00681824
Fibrin Sealant for the Sealing of Dura Sutures
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the efficacy and safety of FS VH S/D 500 s-apr, a double virus-inactivated biological two-component fibrin sealant, for use in posterior fossa surgery as an adjunct to dura and dura substitute sutures in preventing postoperative cerebrospinal fluid (CSF) leakage.
Timeline
- Start
- 2008-05
- Primary completion
- 2010-03
- Completion
- 2010-03
Outcome
Missed primary endpoint
registry p = 0.7159; likelihood ratio of chi squared test NCT00681824 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FS VH S/D 500 s-apr | Protein / enzyme biologic | — | Topical |